All In Biotech

Free tool

FAERS Monitor: Egaten

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208711 or its brand name (Egaten, Triclabendazole). Reports on generic versions are filed under their own applications.

Reports

44

Serious

24

55% of reports

Hospitalization

5

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malaise7
  • trematode infection5
  • fascioliasis4
  • condition aggravated3
  • illness3
  • nausea3
  • overdose3
  • rash3
  • abdominal pain2
  • chest pain2
  • cough2
  • diarrhoea2
  • drug ineffective2
  • fatigue2
  • fracture2

Reports by year received

View as table
YearReports
20181
20195
20209
20213
20225
20234
20246
202511

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,115 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
trematode infectionSignal5159500.960582.2484,477
fascioliasisSignal4119625.741649.5293,077
fracture250.513.054
illnessSignal313.94.724
malaiseSignal77.63.935
overdoseSignal36.62.29
chest pain25.21.33
condition aggravatedSignal34.71.66
abdominal pain24.11.12
cough23.40.91
rash33.31.13
nausea31.80.60
diarrhoea21.50.40
fatigue21.20.30
drug ineffective20.70.20

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.